Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

Middle aged and older adults who are hospitalized for severe infections were more than twice as likely to develop heart failure in the future, a new study shows. Authors say that’s why it’s so ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...

Strict sodium intake — with or without restrictions on fluid intake — is unlikely to confer clinical benefits on patients with heart failure, reported investigators. Their review of studies showed ...

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

Some people with heart failure need to take multiple medicines each day to keep their symptoms under control. Heart failure is a chronic, or long-term, condition. It can lead to issues not only in the ...

Stem cell therapy, or regenerative medicine, uses stem cells or their derivatives to repair, replace, or regenerate diseased, ...